FFR Systems

	Company	Product
	Acist Medical Systems	RXi and RXi Mini Systems
	Acist Medical Systems	RXi Mini Systems
	Company	Product
	Boston Scientific	COMET II
	CathWorks	The CathWorks FFRangio System
	HeartFlow	HeartFlow FFR-CT Analysis
	OpSens Inc.	OptoMonitor - OptoWire
	Philips Healthcare Image Guided Therapy	IntraSight
	Philips Healthcare Image Guided Therapy	Core
	Philips Healthcare Image Guided Therapy	Core Mobile
	Philips Healthcare Image Guided Therapy	SyncVision Precision Guided Therapy System

Machine learning can be used to help clinicians with early diagnosis

CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

March 03, 2023

$The Pie Medical Imaging angiography-based vessel fractional flow reserve (CAAS vFFR) technology can use angiography imaging alone to assess FFR without the need for pressure wires or adenosine.$

News | FFR Technologies

European Trial Evaluates Angiography Vessel Fractional Flow Reserve (vFFR) Guided PCI Versus Conventional FFR

January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently ...

January 04, 2022

An example of HeartFlow's FFR-CT assessment, which shows areas of low blood flow based on computation fluid dynamics from a CT scan of the heart. The vendor's new PreRead software will use AI to clearly and reproducibly identify areas of ischemia due to coronary artery occlusion and act as a second set of eyes for emergency rooms evlautaing chest pain patients.

News | FFR Technologies

HeartFlow Files for FDA Review to Evaluate the Coronary Occlusions and Plaque

December 13, 2021 - HeartFlow Inc., the leader in revolutionizing precision heart care, today announced it has submitted ...

December 13, 2021

$Abbott's fractional flow reserve (FFR) system. #TCT #TCT21 #FAME3$

News | FFR Technologies

FAME 3 Study Finds FFR Guided PCI Did Not Perform as Well at One-year Compared to Bypass Surgery

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

November 09, 2021

News | FFR Technologies

QFR Technology for Advanced Coronary Artery Disease Leads to Improved Outcomes

November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...

November 09, 2021

News | FFR Technologies

Systematic FFR Assessment Did Not Add Benefit During Diagnostic Angiography

September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce ...

September 08, 2021

The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments.

News | FFR Technologies

CathWorks FFRangio System Receives National Reimbursement Approval in Japan

July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the ...

July 26, 2021

An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

News | FFR Technologies

HeartFlow Becomes Publicly Traded Company in Merger With Longview Acquisition Corp.

July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (FFR ...

July 15, 2021

The Philips Healthcare SyncVision system co-registers iFR hemodynamic blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

News | FFR Technologies

First Patient Enrolled in DEFINE GPS Study to Assess PCI Guided by Co-registered iFR Versus Angiography

June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being ...

June 22, 2021

The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease. #ACC21 #ACC2021 #FFR

News | FFR Technologies

No Benefit to FFR-guided PCI in STEMI Patients With Multi-Vessel Disease

May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart attack ...

May 17, 2021

FFR Systems

Related Content